LymeC6antibody test dogs The C6 peptide is a crucial component in the serological diagnosis of Lyme disease, primarily used to detect antibodies against *Borrelia burgdorferi*, the bacterium responsible for the illnesslyme-disease-management-quant-c6 .... This synthetic peptide, derived from the VlsE protein of *B. burgdorferi*, acts as a specific marker, offering a more precise method for identifying infection compared to earlier diagnostic approaches.2Antibodies to the C6 peptide are an indication of natural infection with B. burgdorferi. Surface proteins change with different stages of infection. Osp ... The C6 peptide ELISA (Enzyme-Linked Immunosorbent Assay) has become a widely adopted tool due to its high specificity and sensitivity in detecting antibodies associated with Lyme disease.
The C6 peptide, a 25-amino acid sequence from the IR6 region of the VlsE protein, is recognized for its immunogenic properties and conserved nature across different *Borrelia burgdorferi* strains. This makes it an effective target for antibody detection. When an individual is infected with *B.作者：V Pomelova·2018—We evaluated the utility ofBorrelia burgdorferi sensu stricto (Bb) peptide C6for serologic confirmation of Ixodid Tick-Borne Borrelioses (ITBB) in Russia. burgdorferi*, their immune system produces antibodies, including those that target the C6 peptide. The C6 peptide ELISA works by detecting these specific antibodies in a patient's blood serum.
The diagnostic utility of the C6 peptide has been extensively studied and validated. Research confirms that the C6 peptide ELISA is highly specific for *B. burgdorferi* and demonstrates improved sensitivity and specificity over older antibody testsC6 B. burgdorferi (Lyme) ELISA Kit - A new standard in .... This improved accuracy is critical for accurate Lyme disease diagnosis, which can be challenging due to the variable presentation of symptoms and the potential for cross-reactivity with other conditions.New Test for Lyme Disease:
The C6 peptide ELISA is a cornerstone in the two-tiered testing strategy for Lyme disease. In this approach, an initial screening test, often the C6 peptide ELISA, is performed. If the results are positive, a confirmatory test may be conducted. However, due to the C6 peptide's inherent specificity, it often serves as a reliable indicator of infectionC6 Peptide-Based Multiplex Phosphorescence Analysis ....
Key advantages of the C6 peptide assay include:
* High Specificity: It is less likely to produce false positives by reacting to antibodies from other infections or conditions.
* Sensitivity: It can detect antibodies even in early stages of infection, although sensitivity can vary. Studies suggest it is effective in detecting both IgG and IgM antibodiesThis ELISA detects both IgG and IgM antibodies against theC6 peptide derived from the V1sE protein of Borrelia burgdorferi, the causative agent of Lyme disease ....
* Indicator of Natural Infection: Antibodies to the C6 peptide are considered a direct indication of infection with *B. burgdorferi*.
* Monitoring Treatment: Levels of C6 antibodies can decline following successful treatment, making the test potentially useful for monitoring therapeutic response in both humans and dogs.
While the C6 peptide ELISA is a powerful diagnostic tool, it's important to understand its applications and potential limitations. It is designed to detect antibodies to *Borrelia burgdorferi sensu stricto*, the primary cause of Lyme disease in North America and Europe. However, there is emerging research suggesting that the C6 peptide test may also be helpful in identifying infections with other *Borrelia* species, such as *Borrelia miyamotoi*, which can cause similar tick-borne illnesses.This ELISA detects both IgG and IgM antibodies against theC6 peptide derived from the V1sE protein of Borrelia burgdorferi, the causative agent of Lyme disease ...
Despite its advantages, the C6 peptide assay is not infallibleTwo-Tiered Antibody Testing for Lyme Disease With Use of 2 .... Like all diagnostic tests, it can have false positives or false negatives.Utility of Borrelia burgdorferi sensu stricto C6 Peptide for ... The interpretation of results should always be done in conjunction with a patient's clinical symptoms and exposure history. Furthermore, cut-off values used in C6 peptide-based enzyme immunoassays have been a subject of ongoing analysis to ensure optimal performance.
The field of Lyme disease diagnostics is continuously evolving. While the C6 peptide ELISA remains a standard, newer assays and modifications are being explored. For instance, some laboratories are transitioning to VlsE1/pepC10 based assays, which also target components of the VlsE protein.C6 Titers In Treated and Untreated, Symptomatic Lyme ... Research also continues into multiplex assays that can detect antibodies to multiple *Borrelia* antigens simultaneously, potentially improving diagnostic accuracy and speed.Test ID: FBBC6 Secondary ID: 91899
Related diagnostic approaches include Western blot (WB) testing, which can be used as a confirmatory method, and PCR (Polymerase Chain Reaction) tests, which detect the genetic material of the bacteria rather than the immune response作者：AR Marques·2002·被引用次数：49—Our data confirm that theC6 peptide ELISA is very specific for B. burgdorferiand that it does not detect anti-OspA antibodies in human samples. Because of .... However, for serological detection, the C6 peptide assay stands out for its specific and sensitive identification of antibodies against *Borrelia burgdorferi*. The development of quantitative C6 tests also offers the potential to measure the antibody response more precisely, aiding in diagnosis and treatment monitoring2014年5月19日—A new test, the Borrelia burgdorferi C6 Peptide Antibody assay,is significantly more specific for detection of B. burgdorferi infection....
Join the newsletter to receive news, updates, new products and freebies in your inbox.